The Riskalyze Report: Advisors buy the SPY

At the request of so many investment advisors, my friends at Riskalyze share the big trends in the assets going into and coming out of advisor portfolios every week. The underlying data is aggregated from hundreds of thousands of client accounts across the $120 billion and counting that advisors manage on the Riskalyze platform*. I hope we can uncover interesting trends for you each week…

Riskalyze

September 4th – 10th

Winners (advisor flows TO these investments increased substantially):
  1. S&P 500 (RSP, VOO, SPY)
  2. Energy (XLE, VDE)
  3. Convertibles (CWB)

Losers (advisor flows FROM these investments increased substantially):

  1. Healthcare (IYH, XLV)
  2. 7-10 Year US Treasury (IEF)
  3. American Electric Power (AEP)

Josh here – sometimes it’s simple. This past holiday-shortened week, advisors certainly kept it that way.

They bought large cap US stocks and some energy names while selling out of one of the year’s worst performing groups (Health Care). Says Mike McDaniel, CIO at Riskalyze: “Advisor use of Healthcare decreased over 5% week over week. Advisor use of Energy and S&P related investments increased approximately 5% week over week.”

It ain’t fancy, to just buy the SPY, but is fancy making anyone money this year?

*(to state the obvious, Riskalyze does not share client sensitive data with me or use animals in testing). 

Full Disclosure: Nothing on this site should ever be considered to be advice, research or an invitation to buy or sell any securities, please see my Terms & Conditions page for a full disclaimer.